ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
29 announcements
Dev Labtech Venture Ltd reported revenue from operations of ₹155.2 Cr (+215.4% YoY) and net profit of ₹9 Cr (+2900.0% YoY) for H1 FY27.
Dev Labtech Venture approved issuance of up to 1.37 crore convertible warrants at Rs.13 each to promoters and non-promoters on preferential basis. The issue aggregates Rs.17.81 Crore for cash.
Dev Labtech's shareholders approved raising authorised share capital from ₹25 Crore to ₹31 Crore at an EGM on 5 November 2026. The Memorandum capital clause is amended.
Dev Labtech Venture's EGM passed an authorised capital increase and a convertible warrant issue, both with 100% votes in favour. Promoters did not vote on the warrants.
Dev Labtech Venture held an EGM on 5 November 2026 and filed voting results. Resolution 2, approving convertible warrants on a preferential basis, passed with 100% votes in favour.
Dev Labtech Venture's EGM considered an authorised capital increase and preferential convertible warrants. Voting results follow later; no issue amount or price is stated.
Dev Labtech Venture schedules a board meeting on 6 November 2026 to approve half-year standalone and consolidated results. The trading window stays closed until 48 hours after results are declared.
Dev Labtech Venture Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Dev Labtech Venture will hold an EGM to approve the preferential issue of 1.37 crore convertible warrants, raising ₹17.81 Crore.
Dev Labtech Venture Limited announced an increase in authorized share capital from 50 million to 62 million equity shares, each with a face value of Rs 5.
Dev Labtech Venture approved the preferential issue of 1.37 crore convertible warrants aggregating ₹17.81 crore. The company also increased its authorised share capital for future expansion.
Dev Labtech Venture Ltd has scheduled a board meeting for October 7, 2026, to discuss raising funds via preferential allotment and increasing authorized share capital.
Dev Labtech Venture Limited held its 33rd Annual General Meeting on September 26, 2026. Members considered the adoption of financial statements, director appointment, and related party transactions.
Dev Labtech executed a ₹2.10 Cr working capital facility with HDFC Bank at 8.9% floating interest. The 12-month overdraft is secured against residential and commercial property.
Dev Labtech Venture Limited has issued letters to unregistered shareholders providing a weblink to access the 33rd AGM Notice and Annual Report for FY 2025-26.
Dev Labtech Venture Limited has filed its 33rd Annual Report for the financial year 2025-26 in compliance with SEBI Listing Regulations.
Dev Labtech Venture held a board meeting on August 27, 2026, approving the Directors' Report and scheduling the 33rd Annual General Meeting for September 26, 2026.
The Board approved availing a Rs. 2.10 Crore credit facility from HDFC Bank and decided to withdraw the previously proposed strike-off of its US subsidiary.
Dev Labtech Venture Ltd reported revenue from operations of ₹117.9 Cr (+258.4% YoY) and net profit of ₹9.2 Cr (+1050.0% YoY) for H2 FY26.
Dev Labtech Venture approved its FY26 audited financial results and appointed new internal and secretarial auditors. The board also noted the completion of various corporate actions.
Dev Labtech Venture Ltd scheduled a board meeting for May 29, 2026. Directors will consider and approve audited standalone and consolidated annual financial results.
Dev Labtech Venture Ltd allotted 2,37,26,278 bonus shares in a 1:1 ratio. The move doubles the company's paid-up equity capital without raising additional funds.
Dev Labtech Venture scheduled a board meeting for May 18, 2026. Directors will consider the allotment of bonus equity shares during the session.
Dev Labtech Venture Ltd announced a new ISIN following its 1:2 stock split. The change takes effect on the May 15, 2026 record date.
Dev Labtech Venture Limited has fixed May 15, 2026, as the record date for a 1:2 stock split and a 1:1 bonus issue. Shares of face value Rs. 10 will split into two shares of Rs. 5 each, followed by the issuance of one bonus share for every one existing share held.
Dev Labtech Venture Limited received in-principle approval from BSE for the issuance of up to 2,37,26,278 bonus equity shares. The bonus will be issued in a 1:1 ratio, providing one free equity share for every existing share held. This capitalisation of reserves expands the company's equity base without requiring cash outflow from shareholders.
Dev Labtech Venture Ltd has received shareholder approval to increase its authorized share capital to ₹25 Crore and execute a 1:2 stock split. Additionally, the company amended its object clause to include new business lines in agricultural food products and marine/shipping services, enabling significant operational diversification.
Dev Labtech Venture Limited announced the successful approval of four resolutions via postal ballot with a requisite majority. Resolutions included increasing authorized share capital, altering the MOA's object clause, a stock split, and a bonus share issue. All 101 participating members, representing 88,63,222 votes, voted in favour of the proposals.
Dev Labtech Venture Limited submitted an initial disclosure confirming it does not qualify as a 'Large Corporate' under SEBI criteria for FY 2026. The company reported outstanding borrowings of ₹2.30 Crore as of March 31, 2026. This regulatory filing ensures compliance with debt-raising framework disclosure norms for listed entities.